SCHEMBL12508324

SCHEMBL12508324

COC(=O)NCCCC(NC(=O)OC)C(=O)ON1C(=O)CCC1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX1 P07099 1/20 0.36
▸ SIRT2 Q8IXJ6 1/20 0.32
▸ SIRT1 Q96EB6 1/20 0.32
▸ SIRT3 Q9NTG7 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ KLK7 P49862 1/20 0.32
▸ KLK5 Q9Y337 1/20 0.32
▸ MEN1 O00255 4/20 0.31
▸ KMT2A Q03164 4/20 0.31
▸ CA1 P00915 1/20 0.31
▸ CA2 P00918 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ TDP1 Q9NUW8 2/20 0.31
▸ ATM Q13315 1/20 0.31
▸ FAAH O00519 1/20 0.31
▸ ABHD16A O95870 1/20 0.31
▸ PLA2G7 Q13093 1/20 0.31
▸ NCEH1 Q6PIU2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10017795 0.96 EPHX1 (0.38) EPHX1SIRT2SIRT1SIRT3KLK7
SCHEMBL327848 0.96 EPHX1 (0.38) EPHX1SIRT2SIRT1SIRT3KLK7
SCHEMBL12509746 0.90 SIRT1 (0.38) EPHX1SIRT2SIRT1SIRT3HPGD
SCHEMBL13167106 0.89 ACE (0.36) EPHX1SIRT2SIRT1SIRT3KLK7
SCHEMBL12694367 0.89 FOLH1 (0.39) SIRT2SIRT1SIRT3SMN1; SMN2KLK7
SCHEMBL13339221 0.88 SIRT2 (0.35) SIRT2SIRT1SIRT3KLK7KLK5
SCHEMBL30895563 0.85 MEN1 (0.48) KLK7KLK5MEN1KMT2ACA1
SCHEMBL12604209 0.85 MEN1 (0.48) KLK7KLK5MEN1KMT2ACA1
SCHEMBL2756775 0.84 SIRT2 (0.36) SIRT2SIRT1SIRT3KLK7KLK5
SCHEMBL277624 0.84 SIRT2 (0.38) SIRT2SIRT1SIRT3KLK7KLK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110171166-A1 POLYMER CONJUGATES OF OSTEOCALCIN PEPTIDES NEKTAR THERAPEUTICS 2011-07-14 — — US disclosed
US-20100130684-A1 POLYMER FACTOR IX MOIETY CONJUGATES NEKTAR THERAPEUTICS (US) 2010-05-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130684-A1 POLYMER FACTOR IX MOIETY CONJUGATES F9, F13A1, F8 EPHX1 459/4885SIRT2 4162/4885SIRT1 3966/4885
US-20110171166-A1 POLYMER CONJUGATES OF OSTEOCALCIN PEPTIDES SOST, PTMS, ALPP EPHX1 2271/4885SIRT2 2572/4885SIRT1 1581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback